Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 244 $ 198 $ 7,694,547 $ (6,751,705) $ 943,284
Balance (in Shares) at Dec. 31, 2019 2,438,866 1,978,269      
Common stock issued $ 5 51,995 52,000
Common stock issued (in Shares) 50,460      
Stock-based compensation 18,460 18,460
Net Loss (477,276) (477,276)
Balance at Mar. 31, 2020 $ 244 $ 203 7,765,002 (7,228,981) 536,468
Balance (in Shares) at Mar. 31, 2020 2,438,866 2,028,729      
Balance at Dec. 31, 2020 $ 622 32,358,068 (12,659,895) 19,698,795
Balance (in Shares) at Dec. 31, 2020 6,220,927      
Common stock issued in equity financing, net of issuance costs $ 493 64,166,361 64,166,854
Common stock issued in equity financing, net of issuance costs (in Shares) 4,928,571      
Common stock issued from warrant and option exercises $ 3 72,750 72,753
Common stock issued from warrant and option exercises (in Shares) 31,949      
Stock-based compensation 245,519 245,519
Net Loss (2,452,295) (2,452,295)
Balance at Mar. 31, 2021 $ 1,118 $ 96,842,698 $ (15,112,190) $ 81,731,626
Balance (in Shares) at Mar. 31, 2021 11,181,447